Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on August 6, 2025
Aura Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
ROAD TOWN, British Virgin Islands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (Nasdaq: AUGO) (TSX: ORA) (B3: AURA33) (“Aura” or the “Company”) today announced that it has closed the sale of 897,134 common shares as a result of the partial …
Contract Logistics Market Expected to Touch $300 Billion by 2035, Driven by 4.01% CAGR Growth
The Contract Logistics Market is registering a compound annual growth rate (CAGR) of 4.01% during the forecast period 2025 to 2035. CA, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- In today’s fast-paced global economy, businesses are increasingly …
Taseko Announces Second Quarter Financial and Operational Results
VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) ("Taseko" or the "Company") reports second quarter 2025 Adjusted EBITDA* of $17 million, net income of $22 million ($0.07 per share …
Copa Holdings Reports Second-Quarter Financial Results
PANAMA CITY, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Copa Holdings1, S.A. (NYSE: CPA), today announced financial results for the second quarter of 2025 (2Q25), delivering another quarter of solid profitability and operational excellence. Key highlights include: …
StickerStoke Launches Real-Time 3D Customization for Aprilia Tuareg 660 with Game-Changing VIHR Technology
Revolutionary VIHR Technology Delivers Highly Accurate 3D Renders and Seamless Editing for Precision-Fit Designs QUITO, PICHINCHA, ECUADOR, August 6, 2025 /EINPresswire.com/ -- StickerStoke, a leader in cutting-edge 3D customization for powersports, …
Flooring Market Expected to Touch $ 350 Billion by 2035, Driven by 3.24% CAGR Growth
The Flooring Market was valued at approximately USD 238.82 billion in 2023 and is projected to increase around USD 350 billion by 2035. PARIS, ITALY, August 6, 2025 /EINPresswire.com/ -- Flooring is more than just a functional aspect of a building—it …
Pre-Engineered Buildings Market Size is Forecasted to Reach $ 30,019.93 Million by the year 2030
The pre-engineered buildings market is projected to grow at a CAGR of 13.90% from 2022 to 2030. SYDNEY, AUSTRALIA, August 6, 2025 /EINPresswire.com/ -- In the modern construction landscape, pre-engineered buildings (PEBs) have become increasingly …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 …
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of proprietary oral small molecules Strengthened discovery …
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Enrollment Complete in Cohorts 1 and 2 of MyPEAK™-1 Phase 1b/2 Trial of TN-201 for MYBPC3-associated HCM; Positive DSMB Safety Review Enables Enrollment of Expansion Cohorts Cohort 1 of RIDGE™-1 Phase 1b Trial of TN-401 Enrolled and First PKP2-associated …
Final Investment Decision for 20-year charter of MK II FLNG to Southern Energy in Argentina
Golar LNG Limited (“Golar”) is pleased to announce today that Southern Energy S.A. (“SESA”) has reached Final Investment Decision for the charter of Golar’s 3.5MTPA MK II FLNG, as contemplated under the terms of the definitive agreements executed by SESA …
Keros to Exclusively Prioritize the Clinical Advancement of KER-065
Company Discontinuing Development of Cibotercept (KER-012) Announces Board and Leadership Changes Designed to Support Streamlined Operational Structure and Strategic Realignment LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. …
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
CTIM-76 and CT-95 Phase 1 dose-escalation studies ongoing Cash and cash equivalents of $83.5 million as of June 30, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, Aug. 06, 2025 (GLOBE NEWSWIRE) …
Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2025, …
Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Initiated Phase 1 single-ascending dose/multiple-ascending dose (SAD/MAD) study with M4 positive allosteric modulator (PAM) NMRA-861, with data expected in the first quarter of 2026 Announces prioritization of obesity as lead indication for NMRA-215, a …
HilleVax Reports Second Quarter 2025 Financial Results
BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended June 30, 2025. Second …
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, …
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited …